Tech Company Inital Public Offerings
T2 Biosystems IPO
T2 Biosystems was acquired by . The company's stock became public on 8/7/2014.
Transaction Overview
Company Name
Announced On
8/7/2014
Transaction Type
IPO
Amount
$57,200,000
Proceeds Purpose
Proceeds purposes are on file with company statements at the SEC.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
101 Hartwell Ave.
Lexington, MA 02421
USA
Lexington, MA 02421
USA
Phone
Website
Email Address
Overview
T2 Biosystems (NASDAQ: TTOO) is a diagnostics company ushering in a new wave of innovative products to improve medical decision-making and treatment. Our proprietary biosensor technology was invented by a team of world-renowned scientists at MIT and Massachusetts General Hospital.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
John McDonough
Chief Financial Officer
John Sprague
Chief Scientific Officer
Thomas Lowery
VP - General Counsel
Michael Gibbs
VP - Human Resources
Kelley Morgan
VP - Operations
Alec Barclay
VP - Regulatory Affairs
Sandy Estrada
Browse more venture capital transactions:
Prev: 8/7/2014: Zephyrus Biosciences venture capital transaction
Next: 8/7/2014: Lifetime Oil venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on funding rounds that are announced publicly. VC investment data records reported here are derived from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs